Erick Lucera - Mar 8, 2025 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
EVP, CHIEF FINANCIAL OFFICER
Signature
/s/ Erick Lucera
Stock symbol
EDIT
Transactions as of
Mar 8, 2025
Transactions value $
$0
Form type
4
Date filed
3/27/2025, 04:41 PM
Previous filing
Mar 5, 2025
Next filing
Mar 28, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EDIT Stock Option (right to buy) Award $0 +275K $0.00 275K Mar 8, 2025 Common Stock 275K $1.72 Direct F1
transaction EDIT Stock Option (right to buy) Award $0 +70K $0.00 70K Mar 8, 2025 Common Stock 70K $1.72 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Erick Lucera is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 This option was granted on March 8, 2025 and is scheduled to vest over four years in equal monthly installments beginning on April 8, 2025 through March 8, 2029.
F2 This option was granted on March 8, 2025 and is scheduled to vest in full on September 8, 2026.